A study found that changes in immune cell metabolism may underlie increases in inflammatory signaling molecules in people with pulmonary arterial hypertension (PAH), suggesting that targeting immune cell metabolism could be a treatment strategy for the condition. The study, “Metabolic changes of peripheral blood mononuclear cells are related to the high cytokine levels in patients […] The post Immune cell metabolism may point to PAH treatment strategy appeared first on Pulmonary Hypertens...
